International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic

Coles, Charlotte E.; Aristei, Cynthia; Bliss, Judith; Boersma, Liesbeth; Brunt, Adrian Murray; Chatterjee, Sanjoy; Hanna, G.G.; Jagsi, Reshma; Kaidar‐Person, Orit; Kirby, Anna M.; Mjaaland, Ingvil; Meattini, Icro; Ángel, Luís; Marta, Gustavo Nader; Offersen, Birgitte Vrou; Poortmans, Philip; Rivera, Sofía

doi:10.1016/j.clon.2020.03.006

Cited by 222 publications

(238 citation statements)

References 12 publications

Supporting

Mentioning

208

Contrasting

Unclassified

Order By: Relevance

“…During the COVID‐19 crisis, some international guidelines have been published by European [6] and American [7] experts, that have been recommended by the European Society for Radiotherapy and Oncology (ESTRO) and the American Society for Radiation Oncology (ASTRO), proposing four options to protect cancer patients: delaying irradiation, foregoing it (in very selected cases), ultrashort irradiation schemes, or preoperative irradiation.…”

Section: Resultsmentioning

confidence: 99%

GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain

et al. 2020

View full text Add to dashboard Cite

Breast cancer (BC) is the most common cancer in women in Spain. During the COVID‐19 pandemic caused by the SARS‐CoV‐2 virus, patients with BC still require timely treatment and follow‐up; however, hospitals are overwhelmed with infected patients and, if exposed, patients with BC are at higher risk for infection and serious complications if infected. Thus, health care providers need to evaluate each BC treatment and in‐hospital visit to minimize pandemic‐associated risks while maintaining adequate treatment efficacy. Here we present a set of guidelines regarding available options for BC patient management and treatment by BC subtype in the context of the COVID‐19 pandemic. Owing to the lack of evidence about COVID‐19 infection, these recommendations are mainly based on expert opinion, medical organizations' and societies' recommendations, and some published evidence. We consider this a useful tool to facilitate medical decision making in this health crisis situation we are facing. Implications for Practice This work presents a set of guidelines regarding available options for breast cancer (BC) patient management and treatment by BC subtype in the context of the COVID‐19 pandemic. Owing to the suddenness of this health crisis, specialists have to make decisions with little evidence at hand. Thus, these expert guidelines may be a useful tool to facilitate medical decision making in the context of a worldwide pandemic with no resources to spare.

show abstract

Section: Resultsmentioning

confidence: 99%

GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain

et al. 2020

View full text Add to dashboard Cite

show abstract

“…No positive or suspicious cases were found in our experience both in phase I and in phase II. However, the difference on the reduction of workloads and on the number of positive or suspect patients reported in the national survey consists in the predominance of the COVID-19 cases in the regions of northern Italy and in particular in Lombardy where 10-50% reduction in radiotherapy workloads has been registered, but also in greater organizational awareness due to the increase of national and international guidelines emerging in the meantime in the literature and in the detailed recommendations on the individual tumor pathologies treated in terms of use of hypofractionated regimens [22][23][24][25][26]. In our experience, dose hypofractionation has been used in breast, prostate and palliation cancers.…”

Section: Discussionmentioning

confidence: 99%

COVID-19 and Radiation Oncology: a 2-phase planning in a mono-institutional experience in Central Italy

Caravatta

Rosa

Sciascio

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: COVID-19 in Italy has led to a reorganization of hospital activities with risks of cancer treatments discontinuity. We report a management model in the two phases of the COVID-19 emergency, lockdown phase I and post-lockdown phase II.Methods: Actions were planned in the two phases: workloads of the visits and radiotherapy planning, dedicated routes, measures for triage areas, management of suspected and positive COVID-19 cases, personal protective equipment, environments andintra-institutional meetings and tumor boards management.Results: Comparing our radiotherapy activity in the period March 9- May 4, 2019 with the same period of 2020 in full phase I of the COVID-19 emergency, no changes were observed.First radiotherapy visits, Simulation Computed Tomography and Linear Accelerators treatments were 123, 137 and 151 in 2019 respect to 121, 135 and 170 in 2020.There were no cases of COVID-19 positivity recorded either in patients or in healthcare professionals who were all negative to the buffers performed.Conclusions: The model planned in our experience in both phases has guaranteed continuity of radiotherapy treatments without workload reduction nor treatment interruption ensuring safety of cancer patients, environments and staff.

show abstract

“…Other organizations such as the Association of Breast Surgeons (ABS), the Royal College of Radiologists (RCR), and the Academy of Medical Royal Colleges have also issued recommendations for the management of patients with breast cancer care during this pandemic. [7][8][9][10][11][12][13] While these consensus guidelines serve as a framework for optimizing resources and outcomes, it is important to evaluate each patient to address the urgency of the intervention and the impact of any modification of treatment protocol on the expected outcomes. The underlying principle is that the quality of care should remain unchanged for the prioritized interventions.…”

Section: Breast Cancer Care and Covid-19mentioning

confidence: 99%

Considerations for the Management of Women with Breast Cancer during the COVID-19 Pandemic

Irukulla

Reddy

2020

Indian Journal of Cardiovascular Disease in Women WINCARS

View full text Add to dashboard Cite

Outcomes in cancer patients are strongly influenced by timeliness and quality of multidisciplinary interventions. The COVID-19 pandemic has led to severe disruption in cancer care in many countries. This has necessitated several changes in clinical care and workflow, including resource allocation, team segregation and deferment of many elective procedures. Several international oncological societies have proposed guidelines for the care of patients afflicted with breast cancer during the pandemic with a view to optimize resource allocation and maximize risk versus benefit for the individual and society. Clinicians may utilize these recommendations to adapt patient care, based on the current availability of resources and severity of the COVID-19 pandemic in each region. This article discusses the guidelines for care of patients afflicted with breast cancer during the pandemic.

show abstract

International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic

Abstract: Clinical Oncology j o ur n a l h o m e p a ge : w w w . c l i n i c a l on c o l o gy o n l i ne . n e t

Cited by 222 publications

References 12 publications

GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain

GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain

COVID-19 and Radiation Oncology: a 2-phase planning in a mono-institutional experience in Central Italy

Considerations for the Management of Women with Breast Cancer during the COVID-19 Pandemic

Contact Info

Product

Resources

About